EPS Q/Q spoločnosti Navidea Biopharmaceuticals Inc
Aká je hodnota metriky EPS Q/Q spoločnosti Navidea Biopharmaceuticals Inc?
Hodnota metriky EPS Q/Q spoločnosti Navidea Biopharmaceuticals Inc je -38.46%
Aká je definícia metriky EPS Q/Q?
Štvrťročný rast EPS (Quarterly EPS growth rate) zo štvrťroku na štvrťrok je nárast EPS spoločnosti za posledné štyri štvrťroky v porovnaní s výsledkami z minulých štyroch štvrťrokov.
The earnings per share growth rate is an important factor for judging a company's value. EPS growth rate gives a good picture of the rate at which the company has grown its profitability in respect to the total number of shares. Comparing EPS history with stock price history helps determine the most likely future direction of the stock price.
Earnings per share is the monetary value of earnings per outstanding share of common stock for a company. The EPS is usually calculated as profit without preferred dividends divided by weighted average of common stock shares over the past twelve months.
EPS Q/Q spoločností v sektore Health Care sektor na NYSEMKT v porovnaní so spoločnosťou Navidea Biopharmaceuticals Inc
Čomu sa venuje spoločnosť Navidea Biopharmaceuticals Inc?
navidea biopharmaceuticals, inc., a biopharmaceutical company, focuses on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. it operates through two segments, diagnostic substances and therapeutic development programs. the company develops manocept platform to target the cd206 mannose receptor expressed on activated macrophages. its cd206-targeted drug platform is applicable to a range of diagnostic modalities, including single photon emission computed tomography, positron emission tomography (pet), imaging and topical gamma-scanning, and intra-operative and/or optical-fluorescence detection, as well as delivery of therapeutic compounds that target macrophages, and immune-and inflammation-involved diseases. further, the company offers nav4694, a fluorine-18 labeled pet imaging agent for use as an aid in the imaging and evaluation of patients with signs or symptoms of alzheimer's disease and mild cognitive impairment. in addition, it is de
Firmy s metrikou eps q/q podobnou spoločnosti Navidea Biopharmaceuticals Inc
- Hodnota metriky EPS Q/Q spoločnosti Akzo Nobel NV je -38.71%
- Hodnota metriky EPS Q/Q spoločnosti Aeglea BioTherapeutics Inc je -38.71%
- Hodnota metriky EPS Q/Q spoločnosti InflaRx N.V je -38.71%
- Hodnota metriky EPS Q/Q spoločnosti GE Aerospace je -38.60%
- Hodnota metriky EPS Q/Q spoločnosti Semler Scientific je -38.55%
- Hodnota metriky EPS Q/Q spoločnosti First Foundation Inc je -38.55%
- Hodnota metriky EPS Q/Q spoločnosti Navidea Biopharmaceuticals Inc je -38.46%
- Hodnota metriky EPS Q/Q spoločnosti J&J Snack Foods je -38.41%
- Hodnota metriky EPS Q/Q spoločnosti Stemline Therapeutics je -38.36%
- Hodnota metriky EPS Q/Q spoločnosti Black Diamond Therapeutics Inc je -38.14%
- Hodnota metriky EPS Q/Q spoločnosti AngloGold Ashanti Plc je -38.10%
- Hodnota metriky EPS Q/Q spoločnosti Franklin Resources je -38.10%
- Hodnota metriky EPS Q/Q spoločnosti Allena Pharmaceuticals Inc je -38.10%